World Health Organization : Technical Report Series, No. 329, (P1-P64): World Health Organization Technical Report Series ; World Health Organization Expert Committee on Biological Standardization, No. 329 (p1-p64)

By D. R. Bangham, Dr.

Book Id: WPLBN0000113166
Format Type: PDF eBook
File Size: 2.7 MB
Reproduction Date: 2005

Title:	World Health Organization : Technical Report Series, No. 329, (P1-P64): World Health Organization Technical Report Series ; World Health Organization Expert Committee on Biological Standardization, No. 329 (p1-p64)
Author:	D. R. Bangham, Dr.
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Bangham, Dr, D. R. (n.d.). World Health Organization : Technical Report Series, No. 329, (P1-P64). Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
WHO EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Eighteenth Report The WHO Expert Committee on Biological Standardization met in Geneva from 27 September to 2 October 1965. Dr P. Dorolle, Deputy Director-General, on behalf of the Director- General, welcomed the members of the Committee, as well as the representative of the Food and Agriculture Organization of the United Nations. Recalling the long traditions of the work on biological standardization, the Deputy Director-General stated that most of the members of the Committee had had long association with it and could be depended on to maintain the high standard expected of the Committee. Referring briefly to the agenda before the Committee, he observed that with successive Expert Committees the topics to be considered appeared to increase both in number and in scope. The increasing responsibility taken by these Committees for the formulation of international requirements for biological substances was one of their most important progressive developments. The Deputy Director-General also referred to a resolution of the Eighteenth World Health Assembly l recommending that Member States of WHO should recognize officially certain international standards and units enumerated in the resolution, this list supersedin,o a similar list included in a resolution of a previous World Health Assembly ? These resolutions indicated the interest and recognition by member countries of the work of biological standardization. The use and application of biological standards and of requirements for biological substances were important nationally in medical and public health practice, and had international implications as well, for example in large-scale eradication programmes against communicable diseases and in certain aspects of international quarantine.

Table of Contents
CONTENTS Page GENERA.L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 PHARMACOLOGICAL Antibiotics 1 . Novobiocin . . . . . . . . . . . . . . . . . . . . .6 2 . Ristocetin . . . . . . . . . . . . . . . . . . . . . .6 3 . Nystatin . . . . . . . . . . . . . . . . . . . . . . .6 4 . Paromomycin . . . . . . . . . . . . . . . . . . . .6 5 . Rolitetracycline . . . . . . . . . . . . . . . . . . .7 6 . Colistin . . . . . . . . . . . . . . . . . . . . . . .7 7 . Colistin methane sulfonate . . . . . . . . . . . . . .7 8 . Procaine benzylpenicillin in oil with aluminium monostearate 7 9 . Tylosin . . . . . . . . . . . . . . . . . . . . . . .8 10 . Hygromycin B . . . . . . . . . . . . . . . . . . . .8 11 . Cefalotin . . . . . . . . . . . . . . . . . . . . . .8 12. Lincomycin . . . . . . . . . . . . . . . . . . . . .8 13 . Rifamycin SV . . . . . . . . . . . . . . . . . . . 9. 14 . Semisynthetic penicillins . . . . . . . . . . . . . . . .9 15 . Other antibiotics . . . . . . . . . . . . . . . . . . .9 Hormones. Vitamins. Enzymes Human growth hormone . . . . . . . . . . . . . . . . . . . . . 10 Angiotensins and renins . . . . . . . . . . . . . . . . . . . . . 10 Erythropoietin . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Heparins . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Streptokinase - streptodornase . . . . . . . . . . . . . . . . . . 11 Urokinase . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Other components of the blood coagulation and fibrinolytic systems . 11 Human insulin . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Human rhyrotrophin . . . . . . . . . . . . . . . . . . . . . . . 12 Haemoglobin . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Biological standards and WHO chemical reference substances . . . . 12 IMMUNOLOGICAL Antigens 27 . BCG vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . 13 28 . Old tuberculin . . . . . . . . . . . . . . . . . . . . . . . . . . 14 29 . Other tuberculins . . . . . . . . . . . . . . . . . . . . . . . . . 14 30 . Rabies vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . 15 31 . Typhoid vaccine . . . . . . . . . . . . . . . . . . . . . . . . . 15 32 . Paratyphoid vaccines . . . . . . . . . . . . . . . . . . . . . . . 15 33 . Cholera vaccine . . . . . . . . . . . . . . . . . . . . . . . . . 15 34 . Tetanus toxoid (adsorbed) . . . . . . . . . . . . . . . . . . . . 16 35 . Clostridi~mzo eden1arie71s( alpha) toxoid . . . . . . . . . . . . . . . 16 36 . Measles vaccine (inactivated) . . . . . . . . . . . . . . . . . . . 16 37 . Newcastle disease vaccine (live) . . . . . . . . . . . . . . . . . . 16 38 . Cardiolipin and lecithin (egg) . . . . . . . . . . . . . . . . . . . 16